VeriChip Corporation Supports Legislation Banning Forced Implantation in Humans

DELRAY BEACH, Fla., Jul 06, 2009 (BUSINESS WIRE) — VeriChip Corporation (“VeriChip” or the “Company”) (NASDAQ:CHIP), a provider of radio frequency identification (RFID) systems for healthcare and patient-related needs, announced today it supports Pennsylvania’s House of Representatives’ recent passage of a bill banning the forced implantation of microchips in humans.

VeriChip’s VeriMed(TM) Health Link patient identification system, which utilizes an implantable RFID microchip in combination with a handheld RFID scanner and a secure patient database, provides immediate access to important identification and health information for patients who arrive at an emergency department unable to communicate. The VeriMed Health Link system was cleared by the FDA in 2004 as a Class II medical device and is the first and only implantable microchip cleared by the FDA for patient identification.

Commenting on the legislation, Scott R. Silverman, Chairman of VeriChip, said, “For years, we, as a Company, have enforced a strict privacy policy that starts with the voluntary use of our VeriMed Health Link patient identification system, which includes our implantable microchip, the VeriChip. The primary application of our VeriMed Health Link patient identification system and the VeriChip microchip is to identify high-risk patients and their medical records in an emergency or clinical situation.” Continued Silverman, “In general, we are supportive of legislation that prohibits forced implants. VeriChip, like any other medical device, should be an election by the patient or his or her physician, loved one or guardian. As long as legislators understand the primary application of VeriChip and the benefits it can provide, we support – in fact we started – the voluntary nature of implantable RFID.” On Monday, July 6, 2009, VeriChip will issue an additional release explaining in detail the evolution of its VeriMed Health Link patient identification system, and its current and future applications.

About VeriChip VeriChip Corporation, headquartered in Delray Beach, Florida, has developed the VeriMed(TM) Health Link System for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, cleared for medical use in October 2004 by the United States Food and Drug Administration. To complement its healthcare division, VeriChip Corporation established VeriGreen Energy Corporation in March 2009 to focus and invest in the clean and alternative energy sector.

For more information on VeriChip, please call 1-800-970-2447, or e-mail info@verichipcorp.com . Additional information can be found online at www.verichipcorp.com.

please continue reading: http://www.cnbc.com/id/31760157/site/14081545